Authors
Latest:
Mark Cuban Cost Plus Drugs Affiliate Pharmacy Network Aims to Support Independent PharmaciesA conversation with Erin Albert, MBA, PharmD, JD, DASPL, chief of pharmacy relations, network and privacy, at Cost Plus Drugs.
Latest:
Adverse Effect Burdens of OCS, ICS Use in AsthmaAdverse effects of oral and inhaled corticosteroid use may impact quality of life for people with asthma.
Latest:
Cost Plus Drugs Making Deals with PayersMark Cuban’s Cost Plus Drugs business has entered into agreements with Capital Blue Cross and Rightway.
Latest:
Q&A: How Tragedy is Forcing Change in the PBM IndustryBil Schmidtknecht joined Drug Topics to share his son’s tragic story and how it motivated him to join the greater fight in putting the lives of patients at the forefront of health care.
Latest:
OTC Medications to Treat the Young AthleteA variety of nonprescription treatments, supplements, and patches can alleviate pain for children and adolescents.
Latest:
How Inappropriate Antibiotic Prescribing Harms PatientsAccording to a study, patients are frequently prescribed broad-spectrum antibiotics instead of narrowly tailored antibiotics, which would be more optimized to treat them.
Latest:
Reevaluating the Use of Silver Sulfadiazine Cream in the Management of BurnsOne antimicrobial agent commonly used in the management of burns is silver sulfadiazine.
Latest:
Asembia Does a Great Job Bringing Professionals Together, Experts Say | Asembia 2025The Summit provides a rare opportunity for professionals to dive deep into emerging healthcare technologies and treatment models.
Latest:
mRNA Technology Leads to Advances in HIV Vaccine CandidateResults of a recent preclinical study provide proof of concept that an mRNA HIV vaccine is safe, immunogenic, and induces CD4–T-cell responses.
Latest:
How Digital Prescription Solutions Can Overcome Pharmacy Challenges | NCPDP 2025In the second part of our interview with Miranda Rochol, she discusses challenges regarding digital prescription solutions and the financial burdens these solutions are designed for pharmacists to overcome.
Latest:
Strategies for Independent Pharmacies to Harness Consumer Trends and Meet the CompetitionPharmacies face mounting challenges amid increased competition, rising operational costs, and complex reimbursement models.
Latest:
Lantidra Cell Therapy for Type 1 Diabetes Approved by FDAThe approval was based on safety and efficacy data from 30 participants in 2 open-label, single-arm studies that received 1 to 3 infusions of donislecel.
Latest:
Examining the Risk of Tardive Dyskinesia from AntipsychoticsA recent study highlights the significant frequency of the adverse effect.
Latest:
Reevaluating the Use of Silver Sulfadiazine Cream in the Management of BurnsOne antimicrobial agent commonly used in the management of burns is silver sulfadiazine.
Latest:
Promising Therapies, Treatment Strategies for HR+ Breast Cancer | ASHP MidyearA conversation with Julia L. Ziegengeist, PharmD, BCOP, clinical pharmacist coordinator of breast medical oncology for the Levine Cancer Institute at Atrium Health.
Latest:
Q&A: Pharmacists Can Help Women Combat Hidden Heart Disease RisksA conversation with Katherine Tromp, PharmD, interim dean at Northeast Ohio Medical University College of Pharmacy.
Latest:
Molnupiravir: Oral Antiviral for the Treatment of COVID-19Molnupiravir is an oral antiviral for the treatment of mild to moderate COVID-19 in adults at high risk of severe disease.
Latest:
What To Know: FDA Approves Apomorphine for Parkinson DiseaseExpert highlights the benefits of using apomorphine infusion to provide more consistent medication levels and reduce the unpredictable fluctuations.
Latest:
Reevaluating the Use of Guaifenesin in the Management of Acute Cough Associated With the Common ColdDespite its popularity and its status as an FDA-approved expectorant, evidence to support guaifenesin’s efficacy is limited and conflicting.
Latest:
Tips Pharmacists Can Use to Help Women Experiencing Depression | ASHP MidyearA conversation with Kathleen Vest, PharmD, BCACP, CDCES, FCCP, professor of Pharmacy Practice at Drake University College of Pharmacy and Health Sciences.
Latest:
Thermometers: A ReviewPharmacists must be familiar with the different thermometers so they can ensure proper use by the consumer.
Latest:
Q&A: CDC Alters COVID-19 Recommendations, Leading to Confusion on Pediatric Vaccine SchedulesChildhood immunization guidance in the US faces confusion as the AAP and CDC diverge on COVID-19 vaccine recommendations, impacting parents and providers.
Latest:
FDA: Exblifep Approved for Complicated Urinary Tract InfectionsCefepime/enmetazobactam was granted a 5-year exclusivity extension under GAIN Act legislation.
Latest:
More Than Long COVID, There's Flu and Pneumonia TooEpic research suggests that like COVID-19, flu and other viral pneumonias can result in long-term symptoms like fatigue and brain fog. Why that might be is open question.
Latest:
Ethical, Practical Considerations of Exemptions to Employer Vaccine Mandates for AnxietyDoes anxiety justify an exemption from vaccine mandates among health care workers?
Latest:
FDA Grants Accelerated Approval to Lifileucel, First-Ever Immunotherapy For Unresectable, Metastatic MelanomaThe FDA's decision represents a landmark approval of a tumor-derived cellular therapy in a solid tumor cancer.
Latest:
Drive Value-based Care With Genetic Testing and Precision MedicineThe shift to value-based care in the U.S. has been slow in coming, in large part because providers have continued to cling to the traditional “fee for service” healthcare model that historically has worked well for them.
Latest:
COVID-19 Vaccines: A Focus on SafetyEase patients’ concerns by being well versed in the safety profiles of each vaccine.
Latest:
Q&A: New Career Priorities Emerge for Pharmacists After COVID-19Since the COVID-19 pandemic, pharmacists are reevaluating career paths and calling for greater flexibility, support, and opportunities for professional growth.
Latest:
National Pharmacy Chain Opioid Settlements Poised to Affect Independent PharmaciesStipulations of the settlements include data reporting, annual training, and an independent compliance officer.
